Effect of iron on fluconazole activity against Candida albicans in presence of human serum or monocyte-derived macrophages

Mycopathologia

Volumn 138, Issue 1, 1997, Pages 29-35

  Minn, Yuriko ^b   Brummer, Elmer ^b   Stevens, David A ^a  

^a SANTA CLARA VALLEY MEDICAL CENTER   (United States)

^b NONE

Author keywords

Candida albicans; Fluconazole; Iron; Macrophage; Monocyte derived

Indexed keywords

ANTIFUNGAL AGENT; APOPROTEIN; APOTRANSFERRIN; FLUCONAZOLE; IRON; TRANSFERRIN;

ARTICLE; BLOOD; CANDIDA ALBICANS; DRUG EFFECT; DRUG INTERACTION; GROWTH, DEVELOPMENT AND AGING; HUMAN; MACROPHAGE; METABOLISM; MICROBIOLOGICAL EXAMINATION; MONOCYTE;

ANTIFUNGAL AGENTS; APOPROTEINS; BLOOD; CANDIDA ALBICANS; DRUG INTERACTIONS; FLUCONAZOLE; HUMANS; IRON; MACROPHAGES; MICROBIAL SENSITIVITY TESTS; MONOCYTES; TRANSFERRIN;

CANDIDA ALBICANS;

EID: 0030731473     PISSN: 0301486X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006889108673     Document Type: Article

References (14)

1. Sternberg S. The emerging fungal threat. Science 1994; 266: 1623-1634.
2. Caroline L, Rosner F, Kozinn PJ. Elevated serum iron, low unbound transferrin and candidiasis in acute leukemia. Blood 1969; 34: 441-451.
3. Radke LL, Hahn BL, Wagner DK, Sohnle PG. Comparison of metal-bonding anticandidal activities of serum and abscess fluid supernatants. J Med Vet Mycol 1994; 32: 295-301.
4. Weinberg ED. Iron and infection. Microbiol Rev 1978; 42: 45-66.
5. Meunier F, Aoun M, Gerard M. Therapy of oral candidiasis in the immunocompromised host: a randomized double blind study of fluconazole vs. ketoconazole. Rev Infect Dis 1990; 12: S364-S368.
6. Fromtling RA, Galgiani JN, Pfaller MA, Espinel-Ingroff A, Bartizal KF, Nolte FB, Odds FC, Rinaldi MG, Sugar AM, Villareal K. Multicenter evaluation of a broth macrodilution antifungal susceptibility test for yeasts. Antimicrob Agents Chemother 1993; 37: 39-45.
7. Garcha UK, Brummer E, Stevens DA. Synergy of fluconazole with human monocytes or monocyte-derived macrophages for killing Candida species. J Infect Dis 1995; 172: 1620-1623.
8. Brock JM, Williams PH, Liceaga J, Wooldridge KG. Relative availability of transferrin-bound iron and cell-derived iron to aerobactin-producing and enterochelin-producing strains of Escherichia coli and to other microganisms. Infect Immun 1991; 59: 3185-3190.
9. Ismail A, Lupan DM. Utilization of siderophores by Candida albicans. Mycopathologia 1986; 96: 109-113.
10. Moors MA, Stull TL, Blank KJ, Buckley HR, Mosser DM. A role of complement receptor-like molecules in iron acquisition by Candida albicans. J Exp Med 1992; 175: 1643-1651.
11. Hasenclever HF. The in vitro interactions of Candida albicans, with nonspecific serum proteins. Mycopathologia 1978; 65: 169-176.
12. Roth FJ, Boyd CC, Sagami S, Blank H. An evaluation of the fungistatic activity of serum. J Invest Derm 1959; 32: 549-556.
13. Manns JM, Mosser DM, Buckley HR. Production of a hemolytic factor by Candida albicans. Infect Immun 1994; 62: 5154-5156.
14. Esterly NB, Brammer SR, Crounse RG. The relationship of transferrin and iron to serum inhibition of Candida albicans. J Invest Derm 1967; 49: 437-442.